| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |